Banque Pictet & Cie Sa Obs Eva Sa Transaction History

Banque Pictet & Cie Sa

  • $11 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023
BUY
$0.14 - $0.21 $7,000 - $10,500
50,000 New
50,000 $0
Q2 2022

Aug 08, 2022
SELL
$1.34 - $2.08 $73,700 - $114,400
-55,000 Closed
0 $0
Q1 2022

May 04, 2022
BUY
$1.1 - $2.17 $60,500 - $119,350
55,000 New
55,000 $83,000

Others Institutions Holding OBSV

# of Institutions
2
Shares Held
88K
Call Options Held
0
Put Options Held
0
View Full List

About ObsEva SA

OBSV Quotes by TradingView
  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email